Amount Raised
$6.6 Million
Round Type
Post-IPO Equity
LakewayBiotechnologyHealthcareHealth CarePharmaceuticalBiopharmaDescription
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction (the “Company” or “Anebulo”), today announced that it has agreed to sell an aggregate of 2,264,650 common shares and accompanying warrants to purchase up to 2,264,650 shares of common stock to certain institutional accredited investors through a private investment in public equity (“PIPE”) financing at a price of $2.935 per share and accompanying warrant. The warrants have an exercise price of $4.215 per share, are exercisable immediately, and will expire five years following the date of issuance. The closing of the PIPE is expected to occur on or about September 29, 2022, subject to customary closing conditions.
Quick answer
Anebulo Pharmaceuticals raised $6.6 Million in a Post-IPO Equity round, dated September 26, 2022. Anebulo Pharmaceuticals is based in Lakeway, Texas, United States.
- How much did Anebulo Pharmaceuticals raise?
- Anebulo Pharmaceuticals raised $6.6 Million in a Post-IPO Equity round on September 26, 2022.
- What does Anebulo Pharmaceuticals do?
- Anebulo is developing innovative therapies that will improve the lives of patients suffering from acute cannabinoid intoxication and substance use disorders.
- Where is Anebulo Pharmaceuticals based and how big is it?
- Anebulo Pharmaceuticals is based in Lakeway, Texas, United States.
- Who are the decision-makers at Anebulo Pharmaceuticals?
- Fundz holds 1 contact at Anebulo Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Pharmaceutical around the same time
Companies in the same sectors as Anebulo Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- MBX Biosciences, Inc. raised $47M on November 7, 2022.
- Lipidio Pharmaceuticals raised an undisclosed amount (Series A) on November 10, 2022.
- NRx Pharmaceuticals raised $11M (Debt Financing) on November 7, 2022.
- Biofrontera raised $3.7M (Seed) on October 25, 2022.
- CASI Pharmaceuticals raised an undisclosed amount on September 23, 2022.
- SpringWorks raised $225M (Post-IPO Equity) on September 7, 2022.
Who to call at Anebulo Pharmaceuticals, and when
A new round usually means Anebulo Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Anebulo Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Anebulo Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Anebulo Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Anebulo Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Anebulo Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.